Thymosin Alpha 1 Peptide
Thymosin Alpha 1 is an acetylated 28-amino-acid thymic peptide derived from prothymosin alpha, widely investigated in preclinical literature for its role in cellular immune signaling, T-cell maturation, and innate immune pathway activation. PX1 Research provides high-purity, laboratory-grade Thymosin Alpha 1 verified through RP-HPLC, ESI-MS, and LAL endotoxin testing for rigorous in vitro and animal research models. All reagents supplied by PX1 Research are intended strictly for laboratory experimentation and non-clinical evaluation.
Quick answer
Thymosin Alpha 1 is an acetylated 28-amino-acid thymic peptide derived from prothymosin alpha, widely investigated in preclinical literature for its role in cellular immune signaling, T-cell maturation, and innate immune pathway activation. PX1 Research provides high-purity, laboratory-grade Thymosin Alpha 1 verified through RP-HPLC, ESI-MS, and LAL endotoxin testing for rigorous in vitro and animal research models. All reagents supplied by PX1 Research are intended strictly for laboratory experimentation and non-clinical evaluation.
Key takeaways
- Thymosin Alpha 1 peptide is a synthetic 28-amino-acid sequence identical to the endogenous thymic peptide derived from prothymosin alpha.
- Thymosin Alpha 1 (Ta1) possesses the primary sequence Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH, with a calculated molecular weight of approximately 3108.37 Da.
- Preclinical investigations demonstrate that Thymosin Alpha 1 exerts its effects primarily through the modulation of pattern recognition receptors, specifically Toll-like Receptor 2 (TLR2) and Toll-like Receptor 9 (TLR9) in myeloid and dendritic cell populations.
- A central focus of Thymosin Alpha 1 research is its capacity to induce lineage commitment and maturation in immature thymocytes.
Direct Answer: What Is Thymosin Alpha 1 Peptide?
Thymosin Alpha 1 peptide is a synthetic 28-amino-acid sequence identical to the endogenous thymic peptide derived from prothymosin alpha. In preclinical laboratory research, it is investigated as an immunomodulatory peptide that regulates T-cell differentiation, dendritic cell activation, and Toll-like receptor (TLR) signaling pathways under controlled in vitro and animal experimental conditions.
Isolated originally from bovine thymic tissue (Thymosin Fraction 5), Thymosin Alpha 1 plays a foundational role in thymic cell biology. Research models utilize synthetic thymosin alpha 1 peptide to evaluate downstream cascades involved in cell-mediated immunity without the complex biological variables introduced by crude tissue extracts.
Molecular Structure and Biochemical Profile of Thymosin Alpha 1
Thymosin Alpha 1 (Ta1) possesses the primary sequence Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH, with a calculated molecular weight of approximately 3108.37 Da. The peptide features an N-terminal acetylation that provides structural stability against basic exopeptidase degradation in cell culture media.
In solution, Thymosin Alpha 1 exhibits an amphipathic alpha-helical conformation near its N-terminus, while the C-terminal domain remains predominantly flexible. This structural duality facilitates specific binding interactions with cell-surface receptors and intracellular signaling adapters. High-grade synthetic preparations must maintain correct secondary structure and sequence fidelity, as minor deletion sequences or unblocked N-termini significantly diminish biological potency in ligand-binding assays.
Preclinical Mechanisms of Action: Immune Signaling Pathways
Preclinical investigations demonstrate that Thymosin Alpha 1 exerts its effects primarily through the modulation of pattern recognition receptors, specifically Toll-like Receptor 2 (TLR2) and Toll-like Receptor 9 (TLR9) in myeloid and dendritic cell populations. Binding to these receptors initiates downstream signaling through the MyD88-dependent pathway, subsequently activating Nuclear Factor kappa B (NF-κB) and Mitogen-Activated Protein Kinase (MAPK) cascades.
In vitro assays indicate that TLR activation by Thymosin Alpha 1 leads to the upregulation of Interferon Regulatory Factor 7 (IRF7), triggering type I interferon (IFN-α/β) transcription. This dual activation of inflammatory and antiviral gene programs provides researchers with a robust experimental tool to probe host-pathogen interactions and intracellular signaling dynamics in isolated immune cells.
Cellular Response: T-Cell Maturation and Dendritic Cell Modulation
A central focus of Thymosin Alpha 1 research is its capacity to induce lineage commitment and maturation in immature thymocytes. In murine and cell-culture models, exposure to the peptide accelerates the differentiation of CD4- / CD8- double-negative precursor cells into double-positive and ultimately mature single-positive CD4+ or CD8+ T-lymphocytes.
Furthermore, in vitro studies demonstrate that Thymosin Alpha 1 enhances the functional capacity of mature peripheral T-cells and natural killer (NK) cells. It upregulates interleukin-2 (IL-2) expression and high-affinity IL-2 receptor (IL-2Rα/CD25) display, leading to increased clonal expansion upon antigen presentation. Simultaneously, dendritic cells treated with Thymosin Alpha 1 display increased expression of major histocompatibility complex class I (MHC-I) and co-stimulatory molecules (CD80/CD86), improving antigen processing efficiency in experimental assays.
Comparative Analysis: Thymosin Alpha 1 vs. Related Immune & Regenerative Peptides
When evaluating thymic derivatives and immunomodulatory compounds, researchers frequently compare Thymosin Alpha 1 against other peptide signaling molecules in our broader catalog of research peptides. While Thymosin Alpha 1 targets TLR signaling and adaptive T-cell maturation, Thymosin Beta 4 operates through G-actin monomer sequestration to regulate cell migration, cytoskeletal remodeling, and tissue regeneration.
Similarly, host defense studies contrast Thymosin Alpha 1 with cationic antimicrobial peptides like LL-37, which directly permeabilize microbial membranes, or tissue repair compounds like BPC-157, which influence nitric oxide expression and focal adhesion kinase pathways. Understanding these mechanistic distinctions allows investigators to select the precise peptide ligand required for their specific cell signaling model.
In Vitro and Preclinical Animal Research Applications
In modern laboratory research, Thymosin Alpha 1 is deployed across several key experimental paradigms. In oncology models, investigators utilize the compound to study immune-checkpoint modulation, evaluating how enhanced T-cell infiltration alters tumor microenvironment dynamics in syngeneic rodent models.
In infectious disease models, researchers examine how Thymosin Alpha 1-induced type I interferons suppress viral replication or bacterial load in primary cell cultures. Additional studies published in the PX1 Research Library explore its antioxidant and cytoprotective properties, measuring changes in superoxide dismutase (SOD) activity and glutathione peroxidase levels under oxidative stress conditions.
Laboratory Reconstitution, Handling, and Storage Protocols
To maintain molecular integrity, lyophilized Thymosin Alpha 1 should be stored at -20°C or -80°C in a desiccated environment upon receipt. Prior to opening the vial, allow the container to equilibrate to room temperature to prevent condensation from introducing moisture into the cake.
Reconstitution should be performed under aseptic conditions using sterile laboratory grade solvents. For standard cell culture assays, reconstituting with bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) yields a clear, stable solution. Gentle swirling is recommended; vortexing should be avoided as mechanical shear forces can induce peptide aggregation. Reconstituted aliquots should be stored at -80°C to minimize degradation over repeated freeze-thaw cycles.
Analytical Quality Assurance: HPLC, Mass Spectrometry, and Endotoxin Limits
Because Thymosin Alpha 1 directly interacts with innate pattern recognition receptors such as TLR2 and TLR9, baseline contamination with bacterial lipopolysaccharides (LPS/endotoxin) can yield false-positive results in signaling assays. PX1 Research subjects every batch of Thymosin Alpha 1 to rigorous Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels remain below 0.01 EU/mg.
Purity and identity are independently verified via Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS). Each lot must achieve ≥98.0% purity by peak area integration and display a single sharp molecular ion peak corresponding to the theoretical mass of 3108.37 Da. Laboratory researchers can access these analytical certificates directly through our PX1 Research Quality Hub.
Sourcing Laboratory-Grade Thymosin Alpha 1 from PX1 Research
PX1 Research manufactures and packages all research peptides in compliant, state-of-the-art facilities located in the USA. By adhering to rigorous quality standards and ISO 17025 accredited third-party verification, PX1 ensures that researchers receive consistent, high-purity materials from lot to lot.
Orders placed before cutoff times ship same-day Monday through Friday from our centralized dispatch centers in California and Arizona. Every shipment includes comprehensive analytical documentation, guaranteeing that your laboratory's experimental setup is supported by fully traceable, high-grade reagents.
Frequently Asked Questions
What is the molecular weight and sequence of Thymosin Alpha 1 peptide?
Thymosin Alpha 1 has a molecular weight of 3108.37 Da and consists of 28 amino acids with an N-terminal acetyl group: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH.
What receptor pathways does Thymosin Alpha 1 target in preclinical models?
Preclinical studies show that Thymosin Alpha 1 acts primarily through Toll-like Receptors 2 and 9 (TLR2/TLR9), activating the MyD88 adapter protein, NF-κB, MAPK, and IRF7 transcription factor pathways.
How does Thymosin Alpha 1 compare to Thymosin Beta 4 in laboratory studies?
Thymosin Alpha 1 is primarily an immunomodulatory signaling peptide that targets T-cell differentiation and TLR signaling, whereas Thymosin Beta 4 is an actin-sequestering peptide focused on cell migration, cytoskeletal reorganization, and wound healing models.
What analytical methods verify the purity of Thymosin Alpha 1 from PX1 Research?
Every lot of Thymosin Alpha 1 is analyzed using RP-HPLC for chromatographic purity (≥98%), ESI-MS for molecular mass confirmation, and LAL assays to ensure endotoxin limits remain below 0.01 EU/mg.
What are the recommended reconstitution procedures for Thymosin Alpha 1 in lab settings?
Lyophilized vials should be reconstituted under a laminar flow hood using sterile bacteriostatic water or PBS (pH 7.4). Avoid high-shear vortexing, aliquot into single-use volumes, and store at -80°C to prevent freeze-thaw degradation.
Is Thymosin Alpha 1 peptide stable at room temperature during laboratory handling?
Lyophilized Thymosin Alpha 1 is stable at ambient room temperature for brief transport periods, but long-term storage requires freezing at -20°C or -80°C in a desiccated container. Reconstituted liquid solutions degrade rapidly at room temperature and must be kept cold or frozen.
What endotoxin thresholds are maintained for research-grade Thymosin Alpha 1?
PX1 Research enforces strict endotoxin controls, ensuring that all batches of Thymosin Alpha 1 test below 0.01 EU/mg to prevent background activation of TLR4/NF-κB signaling in cell assays.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.